What Analysts Are Saying About IDEXX Laboratories Stock
Portfolio Pulse from Benzinga Insights
Analysts have mixed ratings for IDEXX Laboratories (NASDAQ:IDXX) with recent price target reductions. The average 12-month price target is $543.75, down 6.25% from the previous $580.00. Despite strong financial metrics, analysts have adjusted their expectations due to market dynamics.
October 11, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEXX Laboratories has received mixed analyst ratings with a recent reduction in the average 12-month price target to $543.75, reflecting a 6.25% decrease. Analysts have adjusted their expectations due to market dynamics, despite the company's strong financial performance.
The reduction in the average price target by analysts indicates a bearish sentiment in the short term, despite IDEXX's strong financial metrics. The adjustments in price targets by key analysts suggest a cautious outlook due to market dynamics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100